High frequency of mutator phenotype in human prostatic adenocarcinoma

Xiang Gao, Ning Wu, David Grignon, Alex Zacharek, Hao Liu, Alicia Salkowski, Gangyong Li, Wael Sakr, Fazlul Sarkar, Arthur T. Porter, Yong Q. Chen, Kenneth V. Honn

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Mutator phenotype of nucleotide repeats has been implicated to be involved in human cancer and other diseases. This type of instability may be the direct result of DNA replication and/or repair errors. To examine mutator phenotype during the development of human prostate cancer, we undertook this study to screen 57 patients with prostatic adenocarcinoma for possible mutator phenotype at 18 microsatellite marker loci on 12 chromosomes (3p, 5q, 6p, 7p, 8p, 10q, 11p, 13q, 16q, 17p, 18q and Xq). Overall, in 37 of 57 patients, we have found positive mutator phenotype in at least one of the loci analysed. A significantly greater number of cases were found to be positive for this phenotype among the poorly differentiated than the moderately- and well-differentiated prostatic adenocarcinomas. Our data suggest that mutator phenotype may play an important role in the development and progression of human prostate cancer.

Original languageEnglish (US)
Pages (from-to)2999-3003
Number of pages5
JournalOncogene
Volume9
Issue number10
StatePublished - Oct 1994
Externally publishedYes

Fingerprint

Adenocarcinoma
Phenotype
Human Development
Prostatic Neoplasms
Chromosomes, Human, Pair 12
DNA Replication
DNA Repair
Microsatellite Repeats
Nucleotides
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

Gao, X., Wu, N., Grignon, D., Zacharek, A., Liu, H., Salkowski, A., ... Honn, K. V. (1994). High frequency of mutator phenotype in human prostatic adenocarcinoma. Oncogene, 9(10), 2999-3003.

High frequency of mutator phenotype in human prostatic adenocarcinoma. / Gao, Xiang; Wu, Ning; Grignon, David; Zacharek, Alex; Liu, Hao; Salkowski, Alicia; Li, Gangyong; Sakr, Wael; Sarkar, Fazlul; Porter, Arthur T.; Chen, Yong Q.; Honn, Kenneth V.

In: Oncogene, Vol. 9, No. 10, 10.1994, p. 2999-3003.

Research output: Contribution to journalArticle

Gao, X, Wu, N, Grignon, D, Zacharek, A, Liu, H, Salkowski, A, Li, G, Sakr, W, Sarkar, F, Porter, AT, Chen, YQ & Honn, KV 1994, 'High frequency of mutator phenotype in human prostatic adenocarcinoma', Oncogene, vol. 9, no. 10, pp. 2999-3003.
Gao X, Wu N, Grignon D, Zacharek A, Liu H, Salkowski A et al. High frequency of mutator phenotype in human prostatic adenocarcinoma. Oncogene. 1994 Oct;9(10):2999-3003.
Gao, Xiang ; Wu, Ning ; Grignon, David ; Zacharek, Alex ; Liu, Hao ; Salkowski, Alicia ; Li, Gangyong ; Sakr, Wael ; Sarkar, Fazlul ; Porter, Arthur T. ; Chen, Yong Q. ; Honn, Kenneth V. / High frequency of mutator phenotype in human prostatic adenocarcinoma. In: Oncogene. 1994 ; Vol. 9, No. 10. pp. 2999-3003.
@article{c84833e8bb8e4bbca4ffde0ec1f097cf,
title = "High frequency of mutator phenotype in human prostatic adenocarcinoma",
abstract = "Mutator phenotype of nucleotide repeats has been implicated to be involved in human cancer and other diseases. This type of instability may be the direct result of DNA replication and/or repair errors. To examine mutator phenotype during the development of human prostate cancer, we undertook this study to screen 57 patients with prostatic adenocarcinoma for possible mutator phenotype at 18 microsatellite marker loci on 12 chromosomes (3p, 5q, 6p, 7p, 8p, 10q, 11p, 13q, 16q, 17p, 18q and Xq). Overall, in 37 of 57 patients, we have found positive mutator phenotype in at least one of the loci analysed. A significantly greater number of cases were found to be positive for this phenotype among the poorly differentiated than the moderately- and well-differentiated prostatic adenocarcinomas. Our data suggest that mutator phenotype may play an important role in the development and progression of human prostate cancer.",
author = "Xiang Gao and Ning Wu and David Grignon and Alex Zacharek and Hao Liu and Alicia Salkowski and Gangyong Li and Wael Sakr and Fazlul Sarkar and Porter, {Arthur T.} and Chen, {Yong Q.} and Honn, {Kenneth V.}",
year = "1994",
month = "10",
language = "English (US)",
volume = "9",
pages = "2999--3003",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - High frequency of mutator phenotype in human prostatic adenocarcinoma

AU - Gao, Xiang

AU - Wu, Ning

AU - Grignon, David

AU - Zacharek, Alex

AU - Liu, Hao

AU - Salkowski, Alicia

AU - Li, Gangyong

AU - Sakr, Wael

AU - Sarkar, Fazlul

AU - Porter, Arthur T.

AU - Chen, Yong Q.

AU - Honn, Kenneth V.

PY - 1994/10

Y1 - 1994/10

N2 - Mutator phenotype of nucleotide repeats has been implicated to be involved in human cancer and other diseases. This type of instability may be the direct result of DNA replication and/or repair errors. To examine mutator phenotype during the development of human prostate cancer, we undertook this study to screen 57 patients with prostatic adenocarcinoma for possible mutator phenotype at 18 microsatellite marker loci on 12 chromosomes (3p, 5q, 6p, 7p, 8p, 10q, 11p, 13q, 16q, 17p, 18q and Xq). Overall, in 37 of 57 patients, we have found positive mutator phenotype in at least one of the loci analysed. A significantly greater number of cases were found to be positive for this phenotype among the poorly differentiated than the moderately- and well-differentiated prostatic adenocarcinomas. Our data suggest that mutator phenotype may play an important role in the development and progression of human prostate cancer.

AB - Mutator phenotype of nucleotide repeats has been implicated to be involved in human cancer and other diseases. This type of instability may be the direct result of DNA replication and/or repair errors. To examine mutator phenotype during the development of human prostate cancer, we undertook this study to screen 57 patients with prostatic adenocarcinoma for possible mutator phenotype at 18 microsatellite marker loci on 12 chromosomes (3p, 5q, 6p, 7p, 8p, 10q, 11p, 13q, 16q, 17p, 18q and Xq). Overall, in 37 of 57 patients, we have found positive mutator phenotype in at least one of the loci analysed. A significantly greater number of cases were found to be positive for this phenotype among the poorly differentiated than the moderately- and well-differentiated prostatic adenocarcinomas. Our data suggest that mutator phenotype may play an important role in the development and progression of human prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=0028169335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028169335&partnerID=8YFLogxK

M3 - Article

C2 - 8084604

AN - SCOPUS:0028169335

VL - 9

SP - 2999

EP - 3003

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 10

ER -